Patent · US Active

Expression system for enhancing solubility and immunogeneicity of recombinant proteins

US7759461B2 · kind B2 · utility

1Cited by
0References
4Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMar 18, 2009
Grant dateJul 20, 2010
Priority date
Expiry dateJun 23, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2740/16322
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Expression system for enhancing solubility and immunogenicity of recombinant proteins. The expression system includes a protein expression vector that contains a chimeric gene encoding a chimeric protein comprising: (a) a first polypeptidyl fragment at the N-terminal end of the chimeric protein, containing a protein transduction domain (PTD), or a fragment thereof, having HIV Tat PTD activity; (b) a second polypeptidyl fragment at the C-terminal end of the first polypeptidyl fragment, containing a J-domain, or a fragment thereof, having heat shock protein 70 (Hsp70)-interacting activity; and (c) a third polypeptidyl fragment at the C-terminal end of the second polypeptidyl fragment, containing a target protein or polypeptide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.